USP DI. Approved drug products and legal requirements.
Saved in:
| Previous Title: | United States pharmacopeia dispensing information |
|---|---|
| Corporate Author: | |
| Format: | Serial |
| Language: | English |
| Published: |
Rockville, Md. :
United States Pharmacopeial Convention,
c1995.
|
| Subjects: | |
| Online Access: | Visit NHRC Library |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 02680cas a2200541 a 4500 | ||
|---|---|---|---|
| 001 | 11284173 | ||
| 003 | 000004 | ||
| 005 | 20220906184639.0 | ||
| 007 | t| | ||
| 008 | 830610d19832007mduar 0 a0eng c | ||
| 022 | 0 | |a 1045-8298 |2 1 | |
| 060 | 0 | 0 | |a QV 736 |
| 082 | 0 | 4 | |a 615/.1 |2 15th |
| 210 | 0 | |a USP DI | |
| 245 | 0 | 0 | |a USP DI. Approved drug products and legal requirements. |
| 246 | 3 | 0 | |a Advice for the patient |
| 246 | 3 | |a United States pharmacopeia dispensing information. Approved drug products and legal requirements. | |
| 246 | 3 | |a USP DI. |n Vol. III, |p Advice for the patient | |
| 260 | |a Rockville, Md. : |b United States Pharmacopeial Convention, |c c1995. | ||
| 300 | |a v. : |c 28 cm. | ||
| 515 | |a Advice for the patient section called also v. 2. | ||
| 580 | |a Updated bimonthly by: USP DI update. | ||
| 580 | |a Published simultaneously with: USP DI. Drug information for the health care provider, and: USP DI. Vol. III, Approved drug products and legal requirements, and: The Complete drug reference. | ||
| 590 | |a SERBIB/SERLOC merged record | ||
| 650 | 0 | |a Drugs |v Periodicals. |9 2402 | |
| 650 | 0 | |a Chemotherapy |v Periodicals. |9 2403 | |
| 650 | 2 | |a Drug Therapy |v Periodicals. |9 2490 | |
| 650 | 2 | |a Drug Therapy |v Popular Works. |9 2491 | |
| 650 | 2 | |a Pharmaceutical Preparations |v Periodicals. |9 2492 | |
| 650 | 2 | |a Pharmaceutical Preparations |v Popular Works. |9 2493 | |
| 650 | 6 | |a Pharmacopées |z États-Unis |v Périodiques. |9 2406 | |
| 650 | 6 | |a Médicaments |x Administration |v Périodiques. |9 2408 | |
| 650 | 6 | |a Médicaments |x Effets secondaires |v Périodiques. |9 2409 | |
| 650 | 6 | |a Médicaments |z États-Unis |v Périodiques. |9 2407 | |
| 655 | 4 | |a Online databases. |9 2494 | |
| 710 | 2 | |a United States Pharmacopeial Convention. |9 2495 | |
| 770 | 1 | |t USP DI update |x 0730-1324 |w (DLC)sn 81006165 |w (OCoLC)5995439 | |
| 776 | 0 | 8 | |i Online version: |t USP DI. Advice for the patient |w (OCoLC)595267118 |
| 776 | 0 | 8 | |i Online version: |t USP DI. Advice for the patient |w (OCoLC)607918335 |
| 780 | 0 | 1 | |t United States pharmacopeia dispensing information |x 0276-5373 |w (DLC) 81640842 |w (OCoLC)5984533 |
| 787 | 1 | |t USP DI. Drug information for the health care provider |x 0740-4174 |w (DLC) 84642138 |w (OCoLC)8796116 | |
| 787 | 1 | |t USP DI. Vol. III, Approved drug products and legal requirements |x 1045-8298 |w (DLC) 89646309 |w (OCoLC)19491595 | |
| 787 | 1 | |t Complete drug reference |w (DLC)sn 91037304 |w (OCoLC)23070944 | |
| 856 | |u http://nhrc.org.np/contact |y Visit NHRC Library | ||
| 942 | |2 NLM |c BK | ||
| 952 | |0 0 |1 0 |2 NLM |4 0 |6 QV_736_000000000000000_USP_1995 |7 0 |9 2086 |a NHRC |b NHRC |d 2014-09-17 |l 0 |o QV 736/USP/1995 |p 000004 |r 2014-09-17 |w 2014-09-17 |y BK | ||
| 984 | |a srvf |d 2002-01-16 | ||
| 999 | |c 2012 |d 2012 | ||